- In April 2024, Medtronic plc expanded its AI-powered endoscopy platform, GI Genius, across multiple global markets, including Asia-Pacific and Europe. The expansion aims to enhance colorectal cancer screening capabilities by integrating AI-assisted polyp detection with robotic endoscopic procedures. This development reinforces Medtronic’s strategy to combine artificial intelligence and robotics for more accurate and efficient diagnostics in minimally invasive procedures
- In March 2024, Intuitive Surgical Inc. announced the next-generation enhancements to its robotic-assisted endoscopic systems, particularly within its da Vinci platform. The updates include improved articulation for endoscopic arms and real-time tissue recognition using machine learning. These upgrades are designed to improve surgical outcomes and expand the usability of robotic endoscopy in complex procedures such as bronchoscopy and thoracic interventions
- In February 2024, Olympus Corporation launched the EVIS X1 endoscopy system with robotic support functionality in select European markets. This platform integrates AI-driven features with robotic navigation tools to enhance visualization and procedural efficiency in gastrointestinal diagnostics. The launch demonstrates Olympus’s continued focus on advancing precision and automation in endoscopic technology
- In January 2024, Asensus Surgical, Inc. announced new clinical partnerships to expand the adoption of its Senhance Surgical System, a digital laparoscopic platform that combines haptic feedback and robotic assistance. These collaborations are aimed at increasing system deployment in hospitals across Latin America and Eastern Europe, promoting robotic-assisted endoscopic surgery in emerging markets
- In December 2023, Brainlab AG introduced a novel robotic-assisted platform for endoscopic neurosurgery, combining high-definition visualization, real-time navigation, and robotic stability. This launch marks Brainlab’s entry into the robotic endoscopy space, with a focus on improving accuracy and minimizing risk in brain tumor and spinal endoscopic procedures, signaling growing diversification in robotic endoscopy applications
